Patents by Inventor Mei-yin Lee

Mei-yin Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND COMPOSITION FOR PREVENTING AND TREATING COVID-19 AND LONG COVID
    Publication number: 20240108681
    Abstract: Coronavirus Disease 2019 (COVID-19) remains a threat with the emergence of new variants, especially Delta and Omicron, without specific effective therapeutic drugs. The present invention provides a method and a composition for preventing and treating COVID-19 (SARS-CoV-2) coronavirus infection which includes administering to a subject in need thereof one or more therapeutically effective doses of Virofree which comprises a pharmaceutically acceptable combination of grape seed extract, acerola cherry extract, olive leaf extract, marigold extract, green tea extract, pomegranate extract, yeast beta-glucan and soya bean extract for a treatment period.
    Type: Application
    Filed: September 11, 2023
    Publication date: April 4, 2024
    Applicant: GLOBAL PREVENTIVE MEDICINE BIOTECH COMPANY LIMITED
    Inventors: MEI-NAN TUAN, HIEN LY DOAN, ZI-YI HUANG, CHIA-YIN LEE, THUC ANH NGUYEN
  • Crystal form
    Patent number: 9694004
    Abstract: A novel crystalline form of a compound is disclosed.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: July 4, 2017
    Assignee: Glaxo Group Limited
    Inventor: Mei-yin Lee
  • Crystal form
    Patent number: 9682074
    Abstract: A novel crystalline form of a compound is disclosed.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: June 20, 2017
    Assignee: Glaxo Group Limited
    Inventor: Mei-yin Lee
  • Novel Crystal Form
    Publication number: 20160367544
    Abstract: A novel crystalline form of a compound is disclosed.
    Type: Application
    Filed: September 1, 2016
    Publication date: December 22, 2016
    Inventor: Mei-yin LEE
  • Crystal form
    Patent number: 9440955
    Abstract: A novel crystalline form of a compound is disclosed.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: September 13, 2016
    Assignee: Glaxo Group Limited
    Inventor: Mei-yin Lee
  • Novel Crystal Form
    Publication number: 20160075685
    Abstract: A novel crystalline form of a compound is disclosed.
    Type: Application
    Filed: November 25, 2015
    Publication date: March 17, 2016
    Inventor: Mei-yin LEE
  • Crystal form
    Patent number: 9227953
    Abstract: A novel crystalline form of rilapladib, and use thereof in treatment of diseases mediated by Lp-PLA2, is disclosed.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: January 5, 2016
    Assignee: Glaxo Group Limited
    Inventor: Mei-yin Lee
  • Novel Crystal Form
    Publication number: 20140213613
    Abstract: A novel crystalline form of a compound is disclosed.
    Type: Application
    Filed: August 31, 2012
    Publication date: July 31, 2014
    Inventor: Mei-yin Lee
  • NOVEL CRYSTALLINE PHARMACEUTICAL PRODUCT
    Publication number: 20120046258
    Abstract: There are provided crystalline particles of unsolvated Form 1 polymorph of the compound of formula (I): characterised in that the particles are in the form of substantially triangular plates.
    Type: Application
    Filed: November 1, 2011
    Publication date: February 23, 2012
    Applicant: GLAXO GROUP LIMITED
    Inventors: Wendy Isabel Cross, Matthew Lawrence Hannan, David Michael Johns, Mei-yin Lee, Christopher John Price
  • Novel Crystalline Pharmaceutical Product
    Publication number: 20090124585
    Abstract: There are provided crystalline particles of unsolvated Form 1 polymorph of the compound of formula (I): characterised in that the particles are in the form of substantially triangular plates.
    Type: Application
    Filed: April 6, 2006
    Publication date: May 14, 2009
    Inventors: Wendy Isabel Cross, Matthew Lawrence Hannan, David Michael Johns, Mei-yin Lee, Christopher John Price